(Q53866809)
Statements
Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancer (English)
Jos H Beijnen
Jan H M Schellens
Theo M de Reijke
Simon Horenblas
Willem Meinhardt
Jeany M Rademaker-Lakhai
Ellen Stokvis